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Abstract
Background: Laparoscopic cholecystectomy (LC) has become the ‘gold standard’ for the treatment of symptomatic
gallstones. Innovative methods are being introduced, and these procedures include transgastric or transcolonic
endoscopic cholecystectomy. However, before clinical implementation, instruments still need modification, and a more
convenient treatment is still needed. Moreover, some gallbladders still have good functionality and cholecystectomy
may be associated with various complications. The aim of this study was to evaluate the trans-gastrointestinal tract
cholecystoscopy technique in the treatment of gallbladder disease without cholecystectomy.
Method: Endoscopic ultrasound (EUS)-guided cholecystoduodenostomy or cholecystogastrostomy with the placement
of a double-flanged fully covered metal stent was performed and endoscopic sphincterotomy (EST) was also performed
during this procedure for those patients with accompanying common bile duct stones. One or two weeks later the stent
was removed and an endoscope was advanced into the gallbladder via the fistula, and cholecystolithotomy or polyp
resection was performed. Four weeks later gallbladder was assessed by abdominal ultrasound.
Results: EUS guided cholecystoduodenostomy (n = 3) or cholecystogastrostomy (n = 4) with double flanged mental stent
deployment was successfully performed in all of 7 patients. After the procedure, fistulas had formed in each of the
patients and the stents were removed. Endoscopic cholecystolithotomy(7) and polyps resection(2) were successfully
performed through the fistulas. Common bile duct stones were also successfully removed in 5 patients. The ultrasound
examination of the gallbladder 4 weeks later showed no stones remaining and also showed satisfactory functioning of
the gallbladder.
Conclusion: The EUS-guided placement of a novel metal stent is a safe and simple approach for performing an
endoscopic cholecystoduodenostomy or cholecystogastrostomy, which can subsequently allow procedures to
be performed for treating biliary disease, including cholecystolithotomy.
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Background
Gallbladder stones and polyps are common benign
diseases of the biliary tract system, often accompanied
by common bile duct(CBD)stones [1, 2]. Laparoscopic
cholecystectomy (LC) or LC plus laparoscopic common
bile duct exploration (LCBDE) are the methods most
widely used to treat symptomatic cases, since they are the
most effective and minimally invasive techniques [3–5].
However, in some cases, the gallbladder still has good
functionality and moreover cholecystectomy may be asso-
ciated with various complications in some patients [6–8].
In previous animal studies we found that newly-developed
lumen apposing metal stent could efficiently accomplish
an anatomosis between the GI tract and the gallbladder
[9]. The fistula formed by the stent may serve as an access
point for endoscopic gallbladder disease treatment. The
aim of this study was to evaluate this trans-gastrointestinal
tract cholecystoscopy technique in treating gallbladder
(GB) disease without the need for cholecystectomy. We
also combined both endoscopic sphincterotomy (EST)
and cholecystolithotomy into a one-session treatment for
those patients who have both gallstones and common bile
duct stones, which could potentially become another
popular alternative to LC plus LCBDE [10].
Method
Patient
Retrospective chart review of patients treated with endo-
scopic cholecystoduodenostomy or cholecystogastrostomy
in our hospital was performed. The inclusion criteria for
the study were as follows: (1) symptomatic gallbladder
stones (Present with upper abdominal pain, not relieved or
exacerbated by movement, position, or bowel function.
Atypical symptom such as chest pain, eructation, early sati-
ety, dyspepsia. Or the symptom caused by complication of
gallstone disease, including cholecystitis, cholangitis, or
pancreatitis) were diagnosed by either CT, US, or MRI; (2)
the gallbladder showed satisfactory function by US (with
the estimated gallbladder ejection fraction greater than
30 % or at stage I or II; and (3) no stone incarceration was
found; (4) the patients were unwilling to receive LC or
medically unfit for LC. Exclusion criteria were: (1) gallblad-
der atrophy and thickening of the cyst wall; (2) coagulopa-
thy; (3) the stone in the cyst duct; and (4) other reasons
that may cause the obstruction of the cystic duct. All
patients provided informed consent for the procedure. This
study was approved by the board of the Shengjing Hospital
of China medical University (NO.2015PS16J).
Devices
Longitudinal echoendoscope (PENTAX EG3870UT,
Pentax Corporation, Japan) with a working channel of
3.8 mm accessible to a 10Fr stent was used. Echo-Tip
needle (19-G, Wilson-Cook Medic, USA) with a lumen
of 0.8 mm in diameter was fitted to a 0.035 in. guidewire
(Tracer metro direct wire guide, 0.035 in. /480 mm,
Wilson Cook Medical Inc, USA). Cystotome (10Fr,
Wilson-Cook Medic) was used to dilate the tract and
create a large fistula. The stent (Micro-Tech/Nan Jing
CO.Ltd. China) had a self-expanding nitinol mesh design,
with 2 large flared ends. Fully expanded, the 2 ends mea-
sured 20 mm in diameter. The waist of the stent measured
10 mm in diameter and the stent was 35 mm long. The 2
large flared ends were designed to protrude against the
adjacent luminal walls with moderate pressure. The stent
was fully covered by a polyester membrane, which prevents
leakage and allows easily retrieval (Fig. 1). The OTSC (over
the scope clips) device was produced by Ovesco Endos-
copy AG, Tuebingen Germany. A nasobiliary drainage
catheter (ENBD,7Fr, Wilson-Cook Medic) was used for
gallbladder drainage.
Procedure
EUS-guided Transmural cholecystoduodenostomy or
cholecystogastrostomy (combined with EST therapy)
The EUS-guided cholecystogastrostomies and per-oral
transgastric cholecystoscopic therapy were all performed
by 1 skilled endoscopist. The patients was under general
anesthesia. For the patients have both gallbladder stones
and CBD stones, a standard EST procedure was per-
formed first. After the CBD stones was cleared, a longi-
tudinal echoendoscope with a working channel of
3.8 mm was introduced into the stomach or duodenal
to scan for the gall bladder and to mark the puncture
point. The contact zone (i.e., the region of the GI wall
representing the shortest distance between the GI and
gall bladder walls) was identified. Color Doppler was
then used to identify interposing vessels in order to
avoid these during the puncture. An EchoTip needle
was introduced via the working channel of the echoen-
doscope, and the gallbladder was punctured under EUS
guidance. A sample was aspirated to confirm that the
punctured structure was gallbladder. 5 ml radiographic
contrast (omnipaque) was injected into the gallbladder.
Several loops of a guide wire were inserted into the
gallbladder, and the needle was removed. The path of
the needle was dilated using a Cystotome.
Under EUS and fluoroscope guidance, the stent was
slowly deployed into the gallbladder and released until
the flared distal end was completely open. Gentle trac-
tion was applied to pull the gallbladder wall close to the
gastric wall. Then, under endoscopic surveillance, the
remainder of the stent was deployed, keeping the prox-
imal end in sight. EUS was used to confirm the position
of the stent and to rule out leakage. After the stent
placement, antibiotics (Ceftriaxone) were administered
intravenously after the procedure for 48 h. The oral diet
was suspended for 48 h. If no complications were observed
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48 h after the procedure the patient’s normal diet could
be resumed.
Per-oral transgastric cholecystoscopic therapy
(cholecystolithotomy or cholecystic polyps resection)
One or two weeks after the cholecystogastrostomy with
metal stent, the fistula between the GI tract and the gall-
bladder had formed. Either CT or X-ray was used to deter-
mine that the stent remained in place. The cholecystoscopy
technique could then be performed with the metal stent in
place or removed. A dilation balloon could be applied to
dilate the tract, if the outer diameter of the endoscope used
to insert into the gallbladder was greater than 8 mm. The
endoscope was advanced into the gallbladder via the fistula
formed by the stent. A stone basket was inserted into the
gallbladder to remove the stones. For the patients had
polyps, a snare or argon plasma coagulation (APC) can be
used for the resection of polyps, and EMR technique could
also be applied.
Following the procedure within the gallbladder, an
ENBD (endoscopic nasobiliary drainage) is placed in the
gallbladder, and 24 h later, radiography performed via
the ENBD tube to check if there are any residual stones.
EGD with transparent cap was applied to check the heal-
ing of the fistula 24 h after the ENBD is removed. If the
GI end of of the fistula was closed, the patient’s normal
diet could be resumed.
Follow up
Four weeks after per-oral transgastric cholecystoscopy, the
contractile response of the patient’s gallbladder should be
assessed by abdominal ultrasound. The gallbladder func-
tions are classified according to a fat meal test (Table 1).
Regular US exam should be done at 1, 3, 6 and 12 months
after the treatment in the first year and every 12 months in
the following years.
Results
A total of 10 patients with symptomatic gallbladder
stone treated at Shengjing Hospital between June 2013
and February 2015 were enrolled in this study. 2 patient
showed gallbladder function of level III was excluded
from this study and the other patient revealed the stone
in the cyst duct were also excluded. 7 patients (3 males
and 4 females), with ages ranging from 60 to 86 years
old, were selected for this procedure (Table 2). 5 patients
were found to have gallbladder stones, 2 patients has
both gallbladder stones and polyps. Five of these patients
complicated by the presence of common bile duct
stones. These diagnoses were all confirmed by CT,MRI
or US.
Cholecystogastrostomy was successfully performed in 2
patients and cholecystogastrostomy combined with EST
therapy was also successfully performed in the other 5 pa-
tients who were complicated with common bile duct stones
(Fig. 1) (Table 3). Most of the patients (6/7) complained of
mild abdominal discomfort following this anastomosis pro-
cedure. One patient complained obvious abdominal pain
Fig. 1 Cholecystogastrostomy. a EUS guided gallbladder puncture by echo-tip needle. b EUS guided stent releasing. c X-ray image of the released
sent. d endoscopic view of the released stent. e CT exam flowing the cholecystogastrostomy
Table 1 Gallbladder function classification (fat meal test)
Grade Empty 30 min 60 min 90 min
I Well-filling cyst of normal
size and shape
obvious >1/2 >3/4
II Mild changes in the
morphology of cyst
mild >1/3 >1/3
III Gallbladder shrinkage and
wall thickening (4–5 mm)
no <1/3 <1/3
IV Atrophy of the cyst no no no
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and distention. The emerging CT scanning revealed the
dilation of the stomach and water retention. The depressing
tube was inserted into the stomach and release the pain. All
7 patients experienced transient increases in Blood leuco-
cytes and 4 developed mild fever, which recovered within
24 h. No signs of peritonitis were observed, and the patients
resumed a normal diet 24 h after the procedure.
Cholecystolithotomy was successfully performed in 7
patients (Table 4), and cholecystic polyp resection was
successfully performed in 2 patients (Fig. 2). The metal
stents were all removed by forceps in 7 patients; this was
done after the transgastric gallbladder therapy in 5 pa-
tients and before the procedure begins in 2 patients. An
ENBD tube was placed in the gallbladder. Twenty-four
hours later, radiography performed via the ENBD tube
showed that the gallbladder was free of residual stones for
the 7 gallbladder stone patients. The pathology of the polyps
from the 2 patients identified these as cholesterol polyps.
The fistula was completely self-closed in 6 patients within
24 h after the removal of the ENBD (checked by EGD). In
one patient, the fistula remained unhealed. Three days after
the cholelithotomy and stent removal, a large amount of
food residual was deposited in the gallbladder with the
fistula unclosed, as revealed by endoscopic examination. An
OTSC device was successfully used to close the fistula after
food residual in the gallbladder was cleaned (Fig. 3).
Four weeks after transgastric cholecystolithotomy, the
contractile response of the patient’s gallbladder was
assessed by abdominal ultrasonography. The gallblad-
der ejection fraction was estimated ranging from 80 to
91 % (86 % on average), which indicated satisfactory func-
tioning at Level 1. During a following up of 3-20months,
no stone recurrence was found in these patients.
Discussion
Choledocholithiasis is a common problem that for almost
the past 300 years has been treated by surgery [6]. A major
step in the treatment of choledocholithiasis was the evolu-
tion from laparotomy to laparoscopy, which today remains
the standard treatment for gallstones. Long-term follow-
up studies have found that cholecystectomy is associated
with an increased incidence of dyspepsia, calculus of the
common bile duct, and colon carcinoma. There are also
serious complications associated with the procedure,
including hemorrhage, bile duct injury, bile leakage, and
abdominal infection [11–13]. For these patients whose still
have good gallbladder functions, gallbladder-preserving
cholecystolithotomy should be considered. Laparoscopic,
transcutaneous and endoscopic methods were reported in
the previous studies [14–18]. In our study, EUS-guided
trans-GI tract cholecystolithotomy has the advantages of
sampler, preciser and less invasive (scarless).
Between 10 and 18 % of patients undergoing laparoscopic
cholecystectomy (LC) for gallbladder stones also have
concurrent common bile duct (CBD) stones [19]. The most
popular approach to treating CBD stones detected prior to
LC is with ERCP, followed by LC [20]. This two-stage
approach has some disadvantages, including the risk of
CBD stone passage taking place between ERCP and LC or
during LC due to excessive gallbladder handling. These
potential problems can be avoided by using the single-
session laparoscopic approach for managing CBD stones
during LC by transcystic exploration (TCE) or laparoscopic
CBD exploration (LCBDE), which is as safe and effective as
the ‘gold standard’ sequential ERCP followed by LC with
Table 2 The characteristic of the patients























aTime: The whole time for the cholecystogastrostomy procedure
Table 4 Per-oral transgastric cholecystoscopic therapy
Duration (days) 9.1
Formation of the fistula 7/7
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the nearly same rate of success, length of hospital stay,
and rate of complications [10]. In this study, we used a
trans-gastrointestinal tract cholecystoscopy technique in
treating GB disease without cholecystectomy, which
may be superior in reduction of residual scarring and in
preserving of gallbladder function. We also combined
EST and cholecystolithotomy into a one-session pro-
cedure for those patients with both gallstones and com-
mon bile duct stones, which may become another
popular alternative treatment option besides LC plus
LCBDE.
Transgastric gallbladder entry through a cholecystogastric
fistula formed as a complication following gallbladder
surgery was first described in a case report by Chen et al.
However, cholecystoenterostomy may also be a complica-
tion of gallstone disease rather than of medical intervention
[21]. EUS has the ability to locate abdominal structure spre-
cisely [22]. In a previous animal study, we evaluated EUS-
assisted transmural cholecystolithotomy performed 4 weeks
after acholecystogastrostomy procedure in which a novel,
fully covered metal stent was inserted in place, guided by
EUS [23, 24]. Transmural cholecystogastrostomy using a
lumen-apposing metal stent may not only be used to facili-
tate gallbladder drainage, but it may also be a technically
easy method for treating cholelithiasis and polyps. The effi-
cient anastomosis formation that we found in our study
could be attributed to the lumen-apposing metal stent,
which has 2 large, flared ends that firmly hold the gastric
wall against the gallbladder wall. The blunted edges of the
flared ends act to prevent further injury to the mucosa. The
covered stents were also found to prevent bile leakage. Over
the past 3 years reports of several types of lumen-apposing
metal stents have been published; these have mainly found
application in endoscopic pancreatic fluid collection drain-
age, gallbladder drainage and common bile duct drainage
[25–31]. EUS-guided transmural cholecystolithotomy by a
metal stent has been reported by Itoi et al., with the stone
removal performed through a lumen-apposing metal stent
in a patient with acute cholecystitis, rather than through a
fistula maturely formed by stent or intended to be applied
Fig. 2 Gastric transmural cholecystolithotomy and polyps resection. a Stone was revealed in the gallbladder by the endoscope. b Stone was
removed from the gallbladder. c Fistula formed by the metal stent (stent was removed). d ENBD was inserted into the gallbladder through the
fistula. e The fistula was closed 3 days following the ENBD removing and ulcer was formed
Fig 3 Fistula closing by OTSC. a Un-healing of the fistula. b The fistula was closed by OTSC
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in patients with good gallbladder function [32]. In our case,
we used this technique as a bridge to facilitate per-oral
cholecystoscopic therapy.
In our clinical study, the EUS-guided cholecystogas-
trostomies were all successfully performed. 7 patients
experienced transient increases in Blood leucocytes and
4 developed mild fever. These incidents may have been
caused by limited leakage of bile taking place during the
procedure,which however did not develop into periton-
itis. Other severe complications such as pneumoperito-
neum, hemorrhage and dislocation of the stent, were not
observed in the patients in this study, which indicates
the safety of this procedure.
The optimal timing of the cholecystoscopic technique
following the cholecystogastrostomy depends on the
maturity of the fistula formed by the stent. It is safe to
allow for 7 days for the fistula dilation, removal of gall-
stones and polyp resection. The fistulas were expected
to completely heal within 24 h after the ENBD was
removed. However, there was 1case of delayed healing of
the fistula found in our study; this fistula was located at
the lesser curvature of the antrum near the pylorus.
Since, in this case, food debris always filled the gallblad-
der, we assumed that the fistula in this location may
have interfered with the gastric emptying function. A
trans-duodenal path may have less impact than a trans-
gastric path in the gastric emptying function, which
could therefore be a better place of puncture. However,
this assumption needs further evaluation. An OTSC de-
vice was used to help in closing the fistula. According to
the literature, the use of OTSC in the closing of a fistula
is not very common [33–35].
It is noteworthy that the ultrasound follow-up evalu-
ation of 20 month showed no gallstone or polyps recur-
rence and the function of the gallbladder remained
satisfactory. Hence this endoscopic gallbladder-preserving
cholecystolithotomy or polyp resection may be an option
for patients with gallstones or polyps but who still have a
well-functioning gallbladder.
Limitations
Reflux of gastric contents into the gallbladder through
the stent may increase the risk of infection and stone
formation. Therefore, the lumen-apposing metal stent
should be further modified so that it has an anti-reflux
function. In addition, it remains unknown as to whether
the pylori function would be interfered with by the loca-
tion of the fistula, so further studies are needed in this
regard. Finally, studies with a larger sample size and a
longer follow-up time are required.
Conclusion
The EUS-guided placement of a novel metal stent is a
safe and simple approach to performing an endoscopic
cholecystogastrostomy, which can subsequently allow for
procedures for treating biliary disease, including chole-
cystolithotomy and polyp resection. Although we cannot
conclude from this case that EUS-guided cholecysto-
lithotomy will replace laparoscopic cholecystectomy and
become the procedure of choice for gallstones, it does
have obvious advantages, especially for the patient with
a gallbladder that is functioning well. It is a minimally-
invasive, scarless procedure that preserves the gallblad-
der and its digestive functions.
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